La cadena de opciones muestra datos clave de las opciones de acciones de Petros Pharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Petros Pharma..

Petros Pharma (NASDAQ:PTPI) Bolsa, Cadena de Opciones

Petros Pharmaceuticals

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

GameStop Corp.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BHIL

BSGM

CISO

CLEU

GDHG

HUMA

IMTE

NYXH

ORKA

PTPI

RAPP

SURG

THTX

TXMD

WINT

ZYBT

El premercado de hoy revela fuertes movimientos bursátiles tras informes financieros y aprobaciones clave en sectores críticos.

Las acciones de GameStop (GME) suben alrededor del 13%; Aquí están 20 acciones que se mueven en el premercado

AEMD

APCX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

DSGN

ELAB

KULR

LITM

MESO

NVNI

QNTM

SGMO

SLXN

VRAX

Acciones de Sangamo Therapeutics suben un 19,5% tras un nuevo acuerdo. Descubre los mayores ganadores y perdedores de hoy.

Acciones de Sangamo Therapeutics (SGMO) suben alrededor de un 20%; 20 acciones que se mueven en el premercado

Earnings

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

NUKK

PRTG

PRZO

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharmaceuticals Inc

PT CHANDRA ASRI PACIFIC by PT Chandra Asri Pacific Tbk

PT Chandra Asri Pacific Tbk

HSIC

Henry Schein One Unveils 2025 Catalyst Index Revealing Key Strategies Driving Top 10% Of Dental Practices And DSOs

<ul>
<li>Acquisition expected to drive 2H 2025 revenue and contribute $15 million to $20 million to 2026 revenue target and growth opportunities for both acoustic and data divisions</li>
<li>Business update call today, May 20, 2025, at 9:00 AM ET</li>
</ul>
Datavault AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) (the "Company" and "Datavault AI"), a leader in AI-driven data experience, valuation and monetization, announced it expects to finalize the strategic acquisition of CompuSystems, Inc. (CSI) assets today, May 20, 2025. In alignment with this milestone, the Company will host a business update call at 9:00 AM ET, as previously announced.
In conjunction with the closing, Datavault will name John Mark LoGiurato as President of the CSI Division of Datavault AI (the "CSI Division"). On May 20, 2025, in connection with Mr. LoGiurato's appointment as President of the CSI Division, Mr. LoGiurato will be granted 500,000 units of restricted stock of Datavault AI (the "Units") as an inducement material to Mr. LoGuirato's entering into employment with the Company. The Units were approved by the board of directors of the Company and granted outside of the Company's 2020 Stock Incentive Plan and 2018 Long-Term Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). In connection with the award of Units, Mr. LoGiurato and the Company have entered into an Inducement Award Agreement for the Units, which agreement contemplates half of the Units vesting in equal 3-month installments over a 36-month period beginning June 20, 2025, and the other half of the Units vesting upon the CSI Division obtaining aggregate revenue equaling or exceeding $25 million over any trailing 12 calendar month period ending on or prior to the date that is 5 years from the grant date.
Datavault AI expects to complete the final steps outlined in the amended asset purchase agreement with CSI today. Following the transaction, CSI's assets and operations will be fully integrated into Datavault AI's business.

Asset Sales

DVLT

Datavault AI To Finalize Strategic Acquisition Of CompuSystems Assets; Deal Expected To Drive 2H 2025 Revenue And Contribute $15M - $20M To 2026 Revenue Target And Growth Opportunities For Both Acoustic And Data Divisions

TXNM

TXNM Energy Appoints Henry Monroy As New CFO Succeeding Retiring Lisa Eden After 21 Years Of Service

TRMB

Trimble Launches End-To-End Materials Management Solution To Help Contractors Control Costs And Streamline Purchasing And Inventory

Southern Company Announces $1.25B Private Offering Of Convertible Senior Notes Due 2028 With Option For Additional $200M

Comparable sales for the first quarter of fiscal 2025 decreased 0.3%, and comparable sales in the U.S. increased 0.2%. For the first quarter of fiscal 2025, foreign exchange rates negatively impacted total company comparable sales by approximately 70 basis points.

Home Depot Q1 Comparable Sales -0.3%, U.S. Comparable Sales +0.2%

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) saw a surge in weekly new vehicle registrations in China as Elon Musk's EV giant grapples with declining sales globally.
What Happened: The company recorded 11,130 insurance registrations for the week of May 12- May 18, 2025, according to a post on X by Tesla Influencer Roland Pircher on Monday.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">For the week of May 12-18, China reported 11.1k insurance registrations for Tesla. &#x1f1e8;&#x1f1f3; The week is up 262.5% from last week and -19.9% year-over-year. The quarter is -5.6% QoQ and -24.2% YoY. This quarter is -43.5% vs. 24Q3 the best quarter after 7 weeks. YTD is at -6.5% YoY. <a href="https://t.co/XibOYIHfZl">pic.twitter.com/XibOYIHfZl</a>
&mdash; Roland Pircher (@piloly) <a href="https://twitter.com/piloly/status/1924681066608013594?ref_src=twsrc%5Etfw">May 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Future Fund LLC's Gary Black shared his thoughts on the data as well, hailing the growth. "$TSLA China reported a solid 11.1K insured registrations for the week of May 12-18. After 7 weeks, the quarter is -5.6% QoQ and -24.2% YoY." He said in a post on X on Monday.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> China reported a solid 11.1K insured registrations for the week of May 12-18. After 7 weeks, the quarter is -5.6% QoQ and -24.2% YoY. Last week's registrations should be a relief to investors after the prior week's disappointing registrations of 3.1K. Sources: <a href="https://twitter.com/piloly?ref_src=twsrc%5Etfw">@piloly</a>… <a href="https://t.co/0h0bmucQh2">pic.twitter.com/0h0bmucQh2</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1924704355606802918?ref_src=twsrc%5Etfw">May 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Black also said how the surge in new registrations could be a source of relief for investors. "Last week's registrations should be a relief to investors after the prior week's disappointing registrations of 3.1K," he said.
Why It Matters: News of the registrations comes in as Tesla is experiencing a decline in sales in the U.S. as well as in various markets in the European region, <a href="https://www.benzinga.com/markets/25/05/45192200/teslas-european-woes-deepen-as-new-car-sales-for-april-plunge-in-spain-as-chinese-rivals-soar">including the likes of Spain</a>.
Musk's EV giant is also reportedly sitting on an inventory of <a href="https://www.benzinga.com/markets/25/05/45216453/tesla-has-over-10000-units-of-unsold-cybertrucks-in-its-us-inventory-amid-poor-sales-report">10,000 unsold Cybertrucks</a> in the U.S. despite releasing a cheaper, RWD trim level of the vehicle in a bid to boost sales.
The company is also accepting<a href="https://www.benzinga.com/25/05/45487522/tesla-is-accepting-trade-ins-for-2024-cybertruck-amid-plummeting-sales-figures-report"> trade-ins for the Cybertruck</a>, only a year after the pickup truck's official launch, signaling a difficult time for the company to move cars off the dealership lots.
Price Action: TSLA Stock currently trades for $344.19 in Pre-Market trading, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45512512/tesla-robotaxi-rival-waymo-announces-california-expansion-as-autonomous-taxi-race-heats-up">Tesla Robotaxi Rival Waymo Announces California Expansion As Autonomous Taxi Race Heats Up</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

Global

Tech

TSLA

Tesla New Vehicle Registrations Surge In China, Gary Black Says It Should Provide Investors Some Relief

Ordinary shares will continue to trade on the Nasdaq Capital Market, and the Company's listing on such exchange is not affected by the receipt of the Notice
SINGAPORE, May 20, 2025 (GLOBE NEWSWIRE) -- FBS Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) disclosed that it had received a notice (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") that FBGL is not currently in compliance with the $1.00 minimum bid price requirement for continued listing of the Company's ordinary shares (the "Ordinary Shares") on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). The Notice indicated that the Company has 180 days, or until November 10, 2025 (the "Compliance Deadline"), to regain compliance with the Minimum Bid Price Requirement by having the closing bid price of the Ordinary Shares meet or exceed $1.00 per Ordinary Share for at least ten consecutive business days.
The Notice has no immediate effect on the listing of the Company's Ordinary Shares, which continue to trade on The Nasdaq Capital Market under the symbol "FBGL". The Company intends to monitor the closing bid price of its Ordinary Shares and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement, including a reverse stock split (i.e., a share consolidation). If the Company does not regain compliance by the Compliance Deadline, the Company may be afforded an additional 180 calendar day period to regain compliance as provided by the Nasdaq Listing Rules.

FBGL

FBS Global Receives Nasdaq Deficiency Notice For Minimum Bid Price Requirement

ZURA

Zura Bio Launches Global Phase 2 TibuSHIELD Study To Evaluate Tibulizumab In Adults With Hidradenitis Suppurativa, Topline Results For Primary Efficacy Endpoint At Week 16, Along With Key Secondary And Exploratory Outcomes, Are Anticipated In Third Quarter Of 2026

Fiscal 2025 Guidance The company reaffirms its guidance for fiscal 2025, a 52-week year compared to fiscal 2024, a 53-week year.&nbsp;
<ul>
<li>Total sales growth of approximately 2.8%&nbsp;</li>
<li>Comparable sales growth of approximately 1.0% for the comparable 52-week period</li>
<li>Approximately 13 new stores</li>
<li>Gross margin of approximately 33.4%</li>
<li>Operating margin of approximately 13.0%</li>
<li>Adjusted(1) operating margin of approximately 13.4%</li>
<li>Tax rate of approximately 24.5%</li>
<li>Net interest expense of approximately $2.2 billion</li>
<li>Diluted earnings-per-share to decline approximately 3% from $14.91 in fiscal 2024</li>
<li>Adjusted(1) diluted earnings-per-share to decline approximately 2% from $15.24 in fiscal 2024</li>
<li>Capital expenditures of approximately 2.5% of total sales</li>
</ul>

Guidance

CORRECTION: Home Depot Affirms FY25 Outlook: Adj EPS Of $14.94 vs. $14.99 Estimate; Sales Of $163.980B vs $164.17B Estimate

SDGR

Schrödinger Appoints Richie Jain As CFO Succeeding Geoffrey Porges Who Will Remain As Advisor Through June 6 For Smooth Transition

Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) reported quarterly earnings of $2.08 per share which missed the analyst consensus estimate of $2.48 by 16.13 percent. This is a 7.14 percent decrease over earnings of $2.24 per share from the same period last year. The company reported quarterly sales of $470.18 million which missed the analyst consensus estimate of $482.11 million by 2.47 percent. This is a 1.37 percent decrease over sales of $476.71 million the same period last year.

Earnings Misses

Eagle Materials Q4 Adj. EPS $2.08 Misses $2.48 Estimate, Sales $470.18M Miss $482.11M Estimate

Needham analyst Ryan Koontz reiterates Gilat Satellite Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILT#NASDAQ">GILT</a>) with a Buy and maintains $8.5 price target.

Price Target

Reiteration

Analyst Ratings

GILT

Needham Reiterates Buy on Gilat Satellite Networks, Maintains $8.5 Price Target

U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket.
The S&amp;P 500 index recorded its <a href="https://www.benzinga.com/25/05/45511478/dow-surges-over-100-points-despite-moodys-us-downgrade-investor-sentiment-decreases-fear-greed-index-remains-in-greed-zone">sixth session of advance</a> by ending marginally higher, shrugging off the <a href="https://www.benzinga.com/news/econ-s/25/05/45479078/moodys-downgrades-us-credit-rating-over-debt-deficit-concerns">Moody&#8217;s downgrade</a> from the weekend.
Experts were assessing the impact of President Donald Trump&#8216;s tax cuts via the proposed &#8216;<a href="https://www.benzinga.com/government/regulations/25/05/45506863/trumps-big-beautiful-bill-advances-heres-who-wins-and-loses">Big, Beautiful Bill</a>,&#8217; as Moody&#8217;s also highlighted the impact of the tax cuts from 2017, and underscored it as a key reason for its decision to downgrade the U.S. credit rating from Aaa to Aa1 on May 16, 2025.
Meanwhile, the 10-year Treasury bond yielded 4.45% and the two-year bond was at 3.96%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 91.4% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.20%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.37%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.45%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.36%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Tuesday. The SPY was down 0.29% to $593.14, while the QQQ declined 0.39% to $519.99, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro </a>data.
Cues From Last Session:
Healthcare, consumer staples, and industrials led the S&amp;P 500&#8217;s Monday gains as U.S. stocks mostly climbed, with the Dow Jones adding over 100 points.
However, energy and consumer discretionary stocks bucked the upward trend, closing lower.
This positive momentum followed a strong prior week where the S&amp;P 500 rose 5.3%, the Dow increased 3.4%, and the Nasdaq Composite surged 7.2%.
Despite Moody&#8217;s downgrading U.S. sovereign credit from Aaa to Aa1, investors showed limited concern. Notably, UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares jumped over 8% on Monday, extending Friday&#8217;s 6% surge, after executives purchased shares during a recent dip.
Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) also soared 15% following FDA approval for its Nuvaxovid COVID-19 vaccine for high-risk individuals.
On the economic front, the CB Leading Index saw a 1% monthly decline in April.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.023%</td>
<td>19,215.46</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.088%</td>
<td>5,963.60</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.32%</td>
<td>42,792.07</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.42%</td>
<td>2,104.43</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
As the S&amp;P 500 index recovered and it was just 2.99% lower than its all-time high of 6,147.43 points, Subu Trade shares data in an X post suggesting that the index tends to rally for 2-12 months after notching such &#8220;quick recoveries.&#8221;
Last time the S&amp;P 500 recovered from -18% to -3% within 50 days, it returned 20.43% on average after one year and 4.86% after three months.
Also, the data shows that the index was higher than 100% of the time after nine months and a year.
&#8220;These quick recoveries tend to see stocks rally more over the next 3-12 months. Momentum is strong,&#8221; the X post stated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 is now -3% below its all-time high. Last month it was -18% below its all-time high. These quick recoveries tend to see stocks rally more over the next 3-12 months. Momentum is strong. <a href="https://t.co/rYzFp9IhSQ">pic.twitter.com/rYzFp9IhSQ</a>
&mdash; Subu Trade (@SubuTrade) <a href="https://twitter.com/SubuTrade/status/1924556261581787515?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, analysts at BlackRock <a href="https://www.benzinga.com/general/market-summary/25/05/45512310/blackrock-bets-on-inflation-goes-overweight-inflation-linked-bonds-amid-us-fiscal-sustainability-challenge-heres-a-list-of-etfs-investors-can-consider">bet on rising inflation</a> by being "overweight" on the inflation-linked bonds. 
This strategic shift is to mitigate risks stemming from "persistent inflation pressure" and growing concerns over the sustainability of U.S. government finances.
The note also highlighted how the U.S. debt sustainability relies on large and steady funding by foreign investors.
"The downgrade reinforces the U.S. fiscal sustainability challenge that we've long flagged, especially persistent U.S. budget deficits at a time when higher interest rates are boosting debt servicing costs. If these dynamics dent the confidence of foreign bond holders, rising term premium could push up bond yields and debt servicing costs even more," explained BlackRock in its note.
As a result, BlackRock&#8217;s current strategy now anticipates higher term premiums for U.S. Treasuries and ongoing inflation.
"That&#8217;s why our starting point also includes our expectation of rising term premium for U.S. Treasuries and persistent inflation pressure. We go overweight inflation-linked bonds and neutral global investment grade credit given wider spreads," the note stated.
Even though U.S. assets are still core to their portfolios, BlackRock&#8217;s shift into inflation-linked bonds highlights their proactive approach to counter looming fiscal and inflationary challenges.
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul class="wp-block-list">
<li>Richmond Fed President Tom Barkin will speak at 9:00 a.m. ET.</li>
<li>Boston Fed President Susan Collins will participate in the &#8216;Fed Listens&#8217; event at 9:30 a.m. ET.</li>
<li>St. Louis Fed President Alberto Musalem will speak at 1:00 p.m., and Federal Reserve Governor Adriana Kugler will speak at 5:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) was 0.36% higher in premarket on Tuesday as analysts expect it to report quarterly earnings of $3.60 per share on revenue of $39.33, before the opening bell.</li>
<li>Toll Brothers Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) was up 0.75% as Wall Street expects it to report earnings after the closing bell. It is expected to post earnings of $2.83 per share on revenue of $2.48 billion.</li>
<li>Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) was 0.026% above the flatline as analysts expect it to report quarterly earnings of 77 cents per share on revenue of $2.28 billion, after the closing bell.</li>
<li>Ekso Bionics Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) dropped 19.34% after announcing a 1-for-15 reverse stock split.</li>
<li>8&#215;8 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) jumped 5% and posted in-line earnings for the fourth quarter on Monday.</li>
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) fell 15.56% after announcing that it will allocate up to 50% of net profits for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) acquisition as part of a new strategic treasury reserve. The company also aims to raise upto $100 million to establish its initial BTC holdings and plans to generate yield through regulated institutional lending and staking.</li>
<li>Lyra Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) dropped 20.21% after announcing a reverse stock split, at 1-for-50, effective from May 27, 2025.</li>
<li>Yalla Group Ltd. ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) slumped 9.08% after the first quarter showed an 8% year-over-year decline in paying users to 11.8 million.</li>
<li>ASP Isotopes Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) zoomed 14.49% after announcing multiple deals with TerraPower involving financial support and future HALEU supply.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.19% to hover around $62.02 per barrel.
Gold Spot US Dollar rose 0.24% to hover around $3,238.07 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.22% at the 100.2010 level.
Asian markets ended higher on Tuesday except South Korea's Kospi and India's S&amp;P BSE Sensex index. Australia's ASX 200, Japan's Nikkei 225, Hong Kong's Hang Seng, and China&#8217;s CSI 300 indices advanced. European markets were higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45510990/federal-reserve-should-do-nothing-at-all-about-the-rising-yields-says-craig-shapiro-let-the-bond-vigilantes-eat">Federal Reserve Should Do &#8216;Nothing At All&#8217; About The Rising Yields, Says Craig Shapiro: &#8216;Let The Bond Vigilantes Eat&#8217; </a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Economics

$BTC

ASPI

EGHT

EKSO

FAAS

LYRA

NVAX

PANW

YALA

US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert

H World Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>) .

HTHT

H World Group sees Q2 2025 revenue growth to be in the range of 1%-5% YoY

H World Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.42 by 19.05 percent. This is unchanged from the same period last year. The company reported quarterly sales of $744.00 million which missed the analyst consensus estimate of $754.09 million by 1.34 percent. This is a 1.78 percent increase over sales of $731.00 million the same period last year.

H World Group Q1 Adj. EPS $0.34 Misses $0.42 Estimate, Sales $744.00M Miss $754.09M Estimate

Turkcell Subsidiary TDC Secures EUR100 Million Murabaha Financing From Emirates NBD To Boost Data Center Investments And Digital Growth

NexGen Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NXE#TSX">NXE</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 80 percent. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year.

TSX:NXE

NexGen Energy Q1 EPS $(0.09) Misses $(0.05) Estimate

MCHP

Microchip Launches PolarFire Core FPGAs And SoCs Offering Up To 30% Cost Savings By Removing Integrated Transceivers

CRSR

Corsair Says It Showcased Powerful New Product Line At Computex Compatible With Latest NVIDIA And AMD GPUs Highlighting Market Share Gains And Ecosystem Growth

Biotech

Press Releases

Petros Pharmaceuticals Featured in "New Era of Healthcare, AI, Data and Consumer Empowerment"

Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, DGLY, LYT, SIGL, Amid FBI Warnings, Signal App Breach, and Data Privacy Crisis"

Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR): Cybersecurity Platform Redefines Privacy

Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

Comments

Petros Pharma

Petros Pharma (PTPI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL